Allison Jeynes-Ellis - 05 Feb 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: Director
Issuer ticker: AGEN
Reported as of: 05 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Apr 2024, 16:05:11 UTC
Prior SEC filing: 08 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/Christine Klaskin, as Attorney-in-Fact for Allison Jeynes-Ellis

Key filing fact

Allison Jeynes-Ellis filed Form 4 for AGENUS INC (AGEN) on 22 Apr 2024.

Key facts

This page summarizes Allison Jeynes-Ellis's Form 4 filing for AGENUS INC (AGEN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Apr 2024, 16:05.

Change

Previous filing in this sequence was filed on 08 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 05 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $12.60
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63.